Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,969 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2013 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

HCG Inj 500un/ml MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-479-2013
Class II · Moderate risk

HCG Inj 1250 un/ml MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-478-2013
Class II · Moderate risk

HCG Inj 1200un/ml MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-477-2013
Class II · Moderate risk

HCG Inj 1000un/ml MDV: 4ml

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-476-2013
Class II · Moderate risk

Folic Acid Inj 5mg/ml MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-475-2013
Class II · Moderate risk

PHMB Opth Soln 0.02%

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-474-2013
Class II · Moderate risk

Dexamethasone Opth Soln 0.1% PF

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-473-2013
Class II · Moderate risk

Chlorhexidine Opth Soln 0.02%

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-472-2013
Class II · Moderate risk

Tobramycin Opth Soln 13mg/ml

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-471-2013
Class II · Moderate risk

Tobramycin Opth Soln 14mg/ml

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-470-2013
Class II · Moderate risk

Vancomycin Opth Soln14mg/ml PF

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-469-2013
Class II · Moderate risk

Vancomycin Opth Soln 25mg/ml PF

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-467-2013
Class II · Moderate risk

Super Trimix #1 Inj MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-466-2013
Class II · Moderate risk

Trimix Inj 30:3:5 MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-464-2013
Class II · Moderate risk

Trimix Inj 30:1:40 MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-463-2013
Class II · Moderate risk

Trimix Inj 30:1:20 MDV: 5 ml

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-462-2013
Class II · Moderate risk

Trimix Inj 30:1:10 MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-461-2013
Class II · Moderate risk

PGE-1 Inj 40mcg/ml MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-460-2013
Class II · Moderate risk

PGE-1 Inj 30mcg/ml MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-459-2013
Class II · Moderate risk

PGE-1 Inj 20mcg/ml MDV: 5ml

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-458-2013

Recalls by year